Koji Kifune
Unitika Ltd.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Koji Kifune.
Journal of Dermatology | 1997
Yasuhiro Horiuchi; Ryoichi Tsurutani; Koji Kifune
To the Editor: Current therapy for systemic lupus erythematosus (SLE) includes corticosteroids, various immunosuppressants, and plasma exchange. However, there can be serious adverse reactions to these drugs. The authors have thus sought to develop a new and safe therapy for SLE. Chitin (1) is a polymer of D-glucosamine, beta-poly-Nacetyl D-glucosamine. From deacetylation ratio values, it has been possible to identify various derivatives of chitin, each with its own degree of immunopotentiating capacity; 70% deacetylated chitin (DAC-70) has been shown to be the most effective immuno-adjuvant (2). In this study, we assessed the use of systemic DAC-70 in treating MRL/lpr lupus mice (3). MRL/Mp-Ipr/lprmice (3), 5 week-old virgin females, were purchased from Charles RiverJapan, Inc. and maintained under specific pathogen free (SPF) conditions in the Experimental Animal House (room temperature, 25°C) of the Unitika Research and Development Center, Kyoto. Eight mice Fig. 1. a) DAC-70 treated mice skin samples show a remarkably reduced degree and/or virtually no staining for IgG at the DE]. (x40) b) The DE] of non-treated mice skin shows strong IgG linear deposition. (x40)
Archive | 1993
Kenji Suzuki; Hiroshi Yoshimura; Hiroshi Matsuura; Tsukasa Kotoh; Teruhisa Nakamura; Ryoichi Tsurutani; Koji Kifune
In order to concentrate anticancer agents in residual cancer cells and to decrease side effects by supressing the systemic concentration of drug, we developed a new drug delivery system, Plachitin, for intraoperative local application after esophagectomy. Chitin and cisplatin were coupled by covalent bond, and in this system chitin was used as a carrier for cisplatin. Chitin is metabolized in the human body by enzymes such as lysozyme and is absorbed in 1–3 months. It is this slow breakdown of chitin that allows Plachitin to release cisplatin over a long period of time and deliver high concentrations of drug to local lesions.
Archive | 1985
Kenzo Motosugi; Koji Kifune; Yasuhiko Yamaguchi; Yasuo Nobe; Hiroyuki Tanae
Archive | 1981
Koji Kifune; Katsuhiro Inoue; Shigeru Mori
Archive | 1985
Koji Kifune; Hiroyuki Tanae; Yasuhiko Yamaguchi; Kenzo Motosugi
Archive | 1991
Ryoichi Tsurutani; Koji Kifune; Yuriko Nakamura
Archive | 1984
Koji Kifune
Archive | 1984
Koji Kifune
Archive | 1989
Koji Kifune; Katsuhiro Inoue; Shigeru Mori
Japanese Journal of Oral & Maxillofacial Surgery | 1998
Kazuhiro Tominaga; Naohiro Tominaga; Michio Tokuhisa; Koji Kifune; Toshio Umemoto; Jinichi Fukuda; Akio Mizuno